YC S21
AOA Dx
Blood Test for Early Detection of Ovarian Cancer
About
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Founders
- Alex Fisher
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in AOA Dx.
See family office activityIndustry & Focus
HealthcareDiagnosticsWomen's Health